Jazz Pharmaceuticals PLC (NAS:JAZZ) Stock News, Headlines & Updates
Jazz Pharmaceuticals PLC Stock News from GuruFocus
- 1
Jun 20, 2024
Jazz Pharmaceuticals Provides Update on Phase 2b Trial of Investigational Suvecaltamide (JZP385) in Essential Tremor
PRNewswire • 7:00am
Jun 01, 2024
Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024
PRNewswire • 8:00am
May 30, 2024
Jazz Pharmaceuticals Showcases Pioneering Research in Sleep Medicine at SLEEP 2024
PRNewswire • 7:00am
May 29, 2024
Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences
PRNewswire • 4:00pm
Zanidatamab Granted Priority Review for HER2-Positive Metastatic Biliary Tract Cancer
PRNewswire • 7:00am
May 23, 2024
Jazz Pharmaceuticals Announces Collaboration With Life Science Cares To Improve the Wellbeing of Under Resourced Communities Through Employee Volunteerism
ACCESSWIRE • 7:00pm
May 22, 2024
Jazz Pharmaceuticals Announces Collaboration with Life Science Cares to Improve the Wellbeing of Under Resourced Communities through Employee Volunteerism
PRNewswire • 8:00am
May 02, 2024
Q1 2024 Jazz Pharmaceuticals PLC Earnings Call Transcript
GuruFocus Research • 11:19pm
May 01, 2024
Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference
PRNewswire • 4:00pm
Apr 30, 2024
Jazz Pharmaceuticals Focuses on Taking Actions To Positively Impact the Planet This Earth Month
ACCESSWIRE • 11:00am
Apr 24, 2024
Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024
PRNewswire • 4:00pm
Apr 23, 2024
Jazz Pharmaceuticals Employees Wear Purple To Support Epilepsy Awareness and Community
ACCESSWIRE • 11:00am
Apr 17, 2024
Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024
PRNewswire • 4:00pm
Apr 10, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news